Tech Company Financing Transactions

ONL Therapeutics Funding Round

ONL Therapeutics closed a $65 million Series D funding round on 9/16/2024. Backers included Johnson & Johnson Innovation, Bios Partners and Novartis Venture Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

PO Box 131547
Ann Arbor, MI 48113
USA

Phone

(734) 998-8339

Website

www.onltherapeutics.com

Email Address

[email protected]

Overview

ONL Therapeutics (ONL) is a biopharmaceutical company committed to protecting and improving the vision of patients with retinal disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Esposito

        

Chief Scientific Officer

David Zacks

        

VP - Bus. Development

Jana Goor

        

VP - R & D

Andrew Kocab

        

Browse more venture capital transactions:

Prev: 9/16/2024: 11xAI venture capital transaction
Next: 9/16/2024: Peratech venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary